About Forest Laboratories
Forest Laboratories is a Healthcare company based in New York (United States) founded in 1954, and was acquired by Actavis in February 2014. Pharmaceutical formulations are developed and marketed by Forest Laboratories. Forest Laboratories has completed 1 acquisition, including Cerexa. Its focus areas include Traditional Pharmaceuticals, Generics and Therapeutic Areas.
Company details
Forest Laboratories was founded in 1954 and is headquartered in New York, United States. Operations focus on the pharmaceutical sector, where formulations are developed and marketed, particularly in central nervous system and cardiovascular therapeutic areas. A pipeline of product candidates spans various development stages and therapeutic fields. Key marketed brands include Bystolic, Daliresp, Fetzima, Linzess, Namenda, Saphris, Savella, Teflaro, Tudorza Pressair, and Viibryd.
Investors in Forest Laboratories
Forest Laboratories has secured backing from 1 investor. Prominent investors backing the company include Actavis.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Manufacturer of generic products | 1956 | actavis.com | Parsippany Troy Hills, United States |
Investor details for Forest Laboratories
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Forest Laboratories
Forest Laboratories has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Cerexa.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Hospital-based anti-infective therapies for antibiotic-resistant infections are developed. | cerexa.com | Alameda, United States | 2005 | Dec 2006 | $493.6M |
Complete acquisition details for Forest Laboratories
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Web traffic of Forest Laboratories
Websites that share an audience with Forest Laboratories (frx.com).
Websites whose visitors overlap most with Forest Laboratories. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
viibryd.com | viibryd.com | 100% | #3,596,624 | – | |
| pfizer.com | 94% | 1.9M | #24,984 | View details | |
| abbott.com | 93% | 917.2K | #65,577 | View details | |
| noven.com | 92% | 7.2K | #3,107,578 | View details | |
| lilly.com | 91% | 4.9M | #13,252 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 24 similar websites and full traffic analytics for Forest Laboratories
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 24 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Forest Laboratories (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | USD 3.02 B | 8,300 | ||
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Forest Laboratories
Forest Laboratories was founded in 1954.
Forest Laboratories is headquartered in New York, United States. It is registered at New York, New York, United States.
Forest Laboratories was founded in 1954 and is headquartered in New York, United States. Operations focus on the pharmaceutical sector, where formulations are developed and marketed, particularly in central nervous system and cardiovascular therapeutic areas. A pipeline of product candidates spans various development stages and therapeutic fields. Key marketed brands include Bystolic, Daliresp, Fetzima, Linzess, Namenda, Saphris, Savella, Teflaro, Tudorza Pressair, and Viibryd.
Forest Laboratories has made 1 acquisition, including Cerexa.
Forest Laboratories has 1 investor. Key investors include Actavis.
Yes. Forest Laboratories was acquired by Actavis in February 2014.